A new antibody that can mount a double attack on the SARS-CoV-2 virus by binding to two different sites on the spike protein is starting human trials, leading to hopes of an antibody therapy that can maintain its effectiveness ...
Mar 25, 2021
0
5
A team of researchers has found disrupting the interaction between cancer cells and certain immune cells is more effective at killing cancer cells than current immunotherapy treatments.
Mar 19, 2021
0
129
The vast majority of people infected with SARS-CoV-2 clear the virus, but those with compromised immunity—such as individuals receiving immune-suppressive drugs for autoimmune diseases—can become chronically infected. ...
Mar 16, 2021
0
172
Evotec, a drug company headquartered in Hamburg, Germany, has begun a phase 1 clinical trial of a monoclonal antibody against the chikungunya virus that was identified at Vanderbilt University Medical Center.
Mar 5, 2021
0
2
Scientists at Cardiff University have discovered a unique way to target a common virus that affects one in 200 newborn babies in the UK but for which there is only limited treatments available.
Feb 16, 2021
0
10
No story in biology is more intriguing than the one involving B cells and the intricate processes that result in antibody production—it's a story about mathematics, a tale of genetics and a saga of how vast armies of tiny ...
Several coronavirus variants have emerged in recent weeks that have got scientists worried. The variants, which were first identified in the UK (B117), South Africa (B1351) and Brazil (P1 and P2), have several mutations in ...
Jan 28, 2021
0
5
The Institute for Research in Biomedicine (IRB; Bellinzona, Switzerland), affiliated with the Università della Svizzera italiana (USI) has developed a second-generation double antibody that protects against SARS-CoV-2, the ...
Jan 25, 2021
0
5
Germany will become the first European Union country to start using the same experimental antibodies treatment credited with helping Donald Trump recover from COVID-19, health minister Jens Spahn said Sunday.
Jan 24, 2021
0
49
The results of a study led by Northern Arizona University and the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, suggest the immune systems of people infected with COVID-19 may rely on antibodies ...
Jan 19, 2021
0
663
